Prosecution Insights
Last updated: October 04, 2026

Shanghai Institute Of Organic Chemistry Chinese Academy Of Sciences

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Shanghai Institute Of Organic Chemistry Chinese Academy Of Sciences currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This specific workload is concentrated under 1 distinct examiner and 1 distinct art unit. The focus of current prosecution activity rests entirely with examiner BORALSKY, LUKE ALAN, who is responsible for the 1 busiest examiner pending office action.

For a practitioner, this centralized portfolio structure means that prosecution outcomes are currently dependent on the assigned personnel at the USPTO. With 1 distinct examiner involved, the applicant lacks the diversity of examiner perspectives that larger portfolios often encounter. The presence of 1 distinct art unit suggests a narrow technological focus for the pending matters within this sector.

The active workload assigned to BORALSKY, LUKE ALAN represents the total current engagement with the office. Monitoring the specific tendencies and past allowance rates of this individual is critical, as there are no other pending actions to balance potential difficulties. This arrangement defines the current landscape for Shanghai Institute Of Organic Chemistry Chinese Academy Of Sciences.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BORALSKY, LUKE ALAN 1 66.7% +44.4%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18462373 PYRIDOPYRIMIDINE-BASED COMPOUND AND APPLICATION THEREOF BORALSKY, LUKE ALAN 54d

Top Art Units

Art UnitApps
1624 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18462373 PYRIDOPYRIMIDINE-BASED COMPOUND AND APPLICATION THEREOF BORALSKY, LUKE ALAN 1624 §112 Non-Final OA 54d Pending Sep 06, 2023

Managing Shanghai Institute Of Organic Chemistry Chinese Academy Of Sciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month